NOVEL ANXIOLYTIC COMPOUND

PROBLEM TO BE SOLVED: To provide GABAA receptor agonists which possess useful therapeutic activity in a range of central nervous system disorders, and in particular, anxiety disorders.SOLUTION: The present invention provides compounds of formula (I'f) and salts thereof.

Saved in:
Bibliographic Details
Main Authors BAELL JONATHAN BAYLDON, STREET IAN PHILLIP, SLEEBS BRAD, FLYNN BERNARD LUKE, QUAZI NURUL, BUI CHINH THIEN
Format Patent
LanguageEnglish
Published 26.09.2013
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:PROBLEM TO BE SOLVED: To provide GABAA receptor agonists which possess useful therapeutic activity in a range of central nervous system disorders, and in particular, anxiety disorders.SOLUTION: The present invention provides compounds of formula (I'f) and salts thereof.
Bibliography:Application Number: JP20130106650